Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide
Yan Wang(Karolinska University Hospital), Xiuping Zhou(Xuzhou Medical College), Ji Qi(Xuzhou Medical College), Qingming Meng(Xuzhou Medical College), Qiang Wang(Jianghan University), Xiang Wang(Weifang Medical University), Xu Wang(Western University), Yu Zhang(Nankai University), Kai Wang(Artificial Intelligence Research Institute), Ding Zhou(Xuzhou Medical College), Er Nie(Jiangsu Province Hospital), Di Wu(Xuzhou Central Hospital), Rutong Yu(Xuzhou Medical College)
Cited by 28
Related Papers
Gas diffusion in coal particles: A review of mathematical models and their applications
|Fuel|2019|310
Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma
|Neuro-Oncology|2017|161
TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
|Journal of Experimental & Clinical Cancer Research|2018|156
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
|Cancer Cell|2018|155
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
|Cell Death and Disease|2018|150